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Successful Treatment of Post-operative Keloid with Combined 
Cryotherapy and Ablative Fractional CO2 Laser
Keloids are pathologic fibroproliferative conditions characterized by 
excessive collagen deposition during wound healing. The pathogenesis of 
keloids is not fully understood, and current treatment options show 
variable results. In this case report, the patient developed a keloid after 
bilateral total thyroidectomy, and was treated with a combination 
approach using fractional ablative laser systems along with cryotherapy 
and triamcinolone injection. After seven monthly sessions of combination 
treatment, the patient presented marked improvement of the scar 
texture and symptoms. Furthermore, there was no recurrence for up to 2 
years. We propose this combination as a safe and effective treatment 
option for keloid patients. 
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Optimal wound healing requires a well-orchestrated 
integration of biological and molecular events regulat-
ing cell migration, proliferation, and extracellular matrix 
(ECM) remodelling.1 Keloids are a pathologic fibroprolifer-
ative condition characterized by excessive collagen depo-
sition during the wound healing.1,2 Numerous treatment 
options have been suggested; cryotherapy, intralesional 
injection, and laser treatment. Nonetheless, keloid treat-
ment remains a challenging condition, and current treat-
ment options still have limitations.1,3 Better understanding 
into the pathogenesis with allow for the development of 
newer and more targeted treatment.
Nowadays, combination approaches using multiple 
laser modalities have shown successful treatment out-
come of hypertrophic scars and keloids.4,5 Combining 
cryotherapy along with fractional and non-fractional laser 
showed good response in many patients.3,6
Herein, we report a case of keloid patient treated with 
combination treatment using fractional ablative lasers 
systems along with cryotherapy and triamcinolone injec-
tion. After monthly seven sessions of combination treat-
ment, the patient presented marked improvement on 
the scar texture and symptoms with no remarkable side 
effects or recurrence over two years.
CASE REPORT
A 21-year-old Korean woman visited the clinic with a 
keloid on the post-thyroidectomy site. The patient un-
derwent a bilateral total thyroidectomy due to thyroid 
adenocarcinoma six months ago. A well-demarcated ery-
thematous firm mass was noted on the patient’s anterior 
neck between the clavicles (Fig. 1A and B). The patient 
presented with pain and pruritus on the keloid and ten-
derness due to traction of the skin. 
After obtaining informed consent, topical anaesthetic 
agent EMLA® cream (eutectic mixture of 2.5% lidocaine 
HCl and 2.5% prilocaine; AstraZeneca AB, Sodertalje, 
Sweden) was applied under occlusion 30 minutes before 
the treatment. The patient was treated with 10,600nm 
ablative fractional CO2 laser using eCO2TM laser (Lutronic 




Fig. 1. (A, B) A keloid scar on the 
anterior neck of the patient. (C, D) 
After five sessions of combination 
treatment with fractional ablative 
CO2 laser followed by cryotherapy 
and triamcinolone injection. (E, F) 
Two year after the initial visit. The 
patient did not show recurrence on 
the treated lesion. 
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cial cryotherapy (CryopPen®, CryoPen Inc., Texas, USA) 
was performed on the laser-irradiated site until achieving 
superficial frosting. A freeze-thaw cycle of ten seconds 
was performed for two cycles. Lastly, intra-lesional in-
jection of triamcinolone 10mg/mL was done. The com-
bination treatment was performed for five session s in a 
monthly follow-up visit. 
After six months, the patient showed telangiectasia on 
the treated lesions with a visible reduction of the keloid 
volume (Fig. 1C and D). The patient was treated with a 
pulsed-dye laser using RegenliteTM (Chromogenix, Swan-
sea, UK) for two additional sessions and instructed to use 
silicone sheet (MegaHeal®, L&C Bio, Seoul, Korea) for at 
least six hours every day. After nine months, the patient 
showed marked improvement in scar texture. During the 
follow-up period for two years, the patient did not show 
additional pain or pruritus without worsening or recur-
rence (Fig. 1E and F).
DISCUSSION
Various treatment options have been suggested for 
keloid, yet no single modality is known to be fully effec-
tive. In most clinical settings, intralesional triamcinolone 
injection remains the first-line therapy for the treatment 
keloids.6,7 However, monotherapy with triamcinolone may 
cause frequent recurrence and high rates of potential 
adverse effects, including skin atrophy, hypopigmentation, 
and telangiectasia. Therefore, the recent advance in clini-
cal studies of scar treatment recommends a combina-
tional approach over monotherapy.3,4,8
The addition of cryotherapy with triamcinolone injec-
tion leads to more rapid response leading to the early 
flattening of the lesions due to microvascular damage.4,7 
Fractional ablative CO2 laser systems are commonly used 
for drug-delivery by creating micro-channels deep into 
the dermis. The use of topical triamcinolone or steroid-
based preparations after fractional CO2 lasers have 
shown a beneficial effect in a hypertrophic scar or keloid 
treatment.7 Recently, our group have reported a retro-
spective review on the effect of combination treatment on 
various types of keloid scars. We believe the addition of 
fractional CO2 laser to the combination of cryotherapy and 
intralesional TA injection may enhance effective delivery 
of triamcinolone to the entire areas of the firm lesions 
of a keloid scar.7,9 Additionally, we used pulsed dye laser 
system to target post-treatment telangiectasia on the 
current patient. Pulsed dye laser systems are known to 
improve the erythema and vascular component of keloid 
scars by improving the pliability of the lesion.3,10 
Despite decades of research, scar treatment remains a 
challenging condition, and current treatment options still 
have limitations—better understanding into the patho-
genesis with allowing for the development of newer and 
more targeted treatment in the future.
The authors suggest that a multimodal approach can 
be applied to target various pathogenic factors in keloid 
scars. And we demonstrated that the combination usage 
of multiple lasers, superficial cryotherapy, and intral-
esional triamcinolone injection is safe and effective for 
keloid patient. Further prospective, controlled investiga-
tions are needed to compare the efficacy of combination 
treatment and suggest the optimal treatment parameters 
for keloid scars.
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